A new approach for clinical biological assay comparison and standardization: Application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits
Jc. Rymer et al., A new approach for clinical biological assay comparison and standardization: Application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits, CLIN CHEM, 45(6), 1999, pp. 869-881
Background: Principal component analysis (PCA) is a powerful mathematical m
ethod able to analyze data sets containing a large number of variables. To
our knowledge, this method is applied here for the first time in the field
of medical laboratory analysis.
Methods: PCA was used to evaluate the results of a blind comparative study
of 21 carcinoembryonic antigen (CEA) reagent kits used to determine CEA con
centration in a panel of sera from 80 patients.
Results: The mathematical technique first eliminated the variations attribu
table to the use of different calibrators. The PCA representation then gave
a global view of the dispersion of the kits and allowed the identification
of a main homogeneous group and of some discrepant kits.
Conclusions: PCA applied to the in vitro diagnostic reagent field could con
tribute to the standardization process and improve the quality of medical l
aboratory analyses. A standardization method using a panel of patient sera
is proposed. (C) 1999 American Association for Clinical Chemistry.